These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6797934)

  • 1. On evasion of Trypanosoma cruzi from the host immune response. Lymphoproliferative responses to trypanosomal antigens during acute and chronic experimental Chagas' disease.
    Kierszenbaum F
    Immunology; 1981 Nov; 44(3):641-8. PubMed ID: 6797934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.
    Kierszenbaum F; Lopez HM; Sztein MB
    Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of lymphocyte responsiveness to polyclonal activators during acute and chronic experimental Trypanosoma cruzi infection.
    Kierszenbaum F; Hayes MM
    Am J Trop Med Hyg; 1980 Jul; 29(4):708-10. PubMed ID: 6773431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental Chagas' disease: kinetics of lymphocyte responses and immunological control of the transition from acute to chronic Trypanosoma cruzi infection.
    Hayes MM; Kierszenbaum F
    Infect Immun; 1981 Mar; 31(3):1117-24. PubMed ID: 6785238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic deficiency during experimental Chagas' disease (Trypanosoma cruzi infection): role of adherent, nonspecific esterase-positive splenic cells.
    Kierszenbaum F
    J Immunol; 1982 Nov; 129(5):2202-5. PubMed ID: 6811661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection.
    Curotto de Lafaille MA; Barbosa de Oliveira LC; Lima GC; Abrahamsohn IA
    Exp Parasitol; 1990 Feb; 70(2):164-74. PubMed ID: 2105229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.
    Kotner J; Tarleton R
    Infect Immun; 2007 Feb; 75(2):861-9. PubMed ID: 17101658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton's tyrosine kinase.
    Gao W; Pereira MA
    Eur J Immunol; 2001 May; 31(5):1503-12. PubMed ID: 11465107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: deficient lymphocyte reactivity during experimental acute Chagas' disease in the absence of suppressor T cells.
    Kierszenbaum F; Budzko DB
    Parasite Immunol; 1982 Nov; 4(6):441-51. PubMed ID: 6218465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.
    Sztein MB; Kierszenbaum F
    Immunology; 1992 Oct; 77(2):277-83. PubMed ID: 1427979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity in Chagas' disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi.
    Rizzo LV; Cunha-Neto E; Teixeira AR
    Infect Immun; 1989 Sep; 57(9):2640-4. PubMed ID: 2474498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies.
    Hernández-Munaín C; De Diego JL; Alcina A; Fresno M
    J Exp Med; 1992 Jun; 175(6):1473-82. PubMed ID: 1375261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune suppression to Trypanosoma cruzi antigens is associated with infection but not immunisation.
    Britten V; Hudson L
    Trop Med Parasitol; 1986 Jun; 37(2):97-100. PubMed ID: 3092341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
    Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
    Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor cells present in the spleens of Trypanosoma cruzi-infected mice.
    Ramos C; Schädtler-Siwon I; Ortiz-Ortiz L
    J Immunol; 1979 Apr; 122(4):1243-7. PubMed ID: 109508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression.
    Beltz LA; Sztein MB; Kierszenbaum F
    J Immunol; 1988 Jul; 141(1):289-94. PubMed ID: 3132504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection.
    Galvão da Silva AP; de Almeida Abrahamsohn I
    Immunology; 2001 Nov; 104(3):349-54. PubMed ID: 11722650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired cell-mediated immunodepression in acute Chagas' disease.
    Teixeira AR; Teixeira G; Macêdo V; Prata A
    J Clin Invest; 1978 Dec; 62(6):1132-41. PubMed ID: 107195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.